1397 CDR404, an antibody-based bispecific & bivalent T-cell engager targeted against MAGE-A4, for Squamous Non-Small Cell Lung Cancer (SQ-NSCLC)
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
DOI:
10.1136/jitc-2023-sitc2023.1397
Publication Date:
2023-10-31T14:50:25Z
AUTHORS (18)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....